Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
In the last 90 days, Nuvectis Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Nuvectis Pharma, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −4 vs. Q2 2023
- Shares held
- 1.28M
- +24.4K (+1.9%) vs. Q2 2023
- Total value
- $16.5M
- −$3.57M (−17.8%) vs. Q2 2023
- New holders
- 1
- 14 more added
- Sold out
- 5
- 13 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $189.0M |
| Q1 2026 | 62 | $34.9M |
| Q4 2025 | 48 | $32.0M |
| Q3 2025 | 53 | $22.2M |
| Q2 2025 | 47 | $24.2M |
| Q1 2025 | 33 | $20.0M |
| Q4 2024 | 31 | $7.15M |
| Q3 2024 | 31 | $6.60M |
| Q2 2024 | 41 | $7.63M |
| Q1 2024 | 40 | $12.8M |
| Q4 2023 | 36 | $12.6M |
| Q3 2023 | 33 | $16.5M |
| Q2 2023 | 37 | $20.0M |
| Q1 2023 | 13 | $6.34M |
| Q4 2022 | 11 | $7.38M |
| Q3 2022 | 12 | $10.0M |
| Q2 2022 | 11 | $7.20M |
| Q1 2022 | 8 | $4.65M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Nuvectis Pharma, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 359,447 | $4.63M | 0.00% | +44,956+14.3% | Added |
| Vanguard Group Inc | 291,134 | $3.75M | 0.00% | +25,196+9.5% | Added |
| Geode Capital Management, LLC | 129,663 | $1.67M | 0.00% | +17,127+15.2% | Added |
| Baldwin Brothers Inc | 116,380 | $1.50M | 0.13% | +26,319+29.2% | Added |
| State Street Corp | 108,122 | $1.39M | 0.00% | +2,882+2.7% | Added |
| Northern Trust Corp | 54,687 | $704.9K | 0.00% | +1,053+2.0% | Added |
| Marshall Wace, LLP | 36,085 | $465.1K | 0.00% | −5,690−13.6% | Reduced |
| Forbes J M & Co LLP | 34,000 | $438.3K | 0.06% | −33,000−49.3% | Reduced |
| Renaissance Technologies LLC | 25,400 | $327.0K | 0.00% | −11,000−30.2% | Reduced |
| Charles Schwab Investment Management Inc | 19,920 | $256.8K | 0.00% | +1,925+10.7% | Added |
| Bank of New York Mellon Corp | 19,150 | $246.8K | 0.00% | 00.0% | Unchanged |
| Moran Wealth Management, LLC | 16,697 | $215.2K | 0.01% | +16,697 | New |
| Nuveen Asset Management, LLC | 10,669 | $137.5K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,282 | $93.9K | 0.00% | +6,739+1,241.1% | Added |
| Rhumbline Advisers | 7,273 | $93.7K | 0.00% | +495+7.3% | Added |
| Bank of America Corp | 6,138 | $79.1K | 0.00% | +4,782+352.7% | Added |
| New York State Common Retirement Fund | 5,772 | $74.4K | 0.00% | +72+1.3% | Added |
| JPMorgan Chase & Co | 4,902 | $63.2K | 0.00% | −558−10.2% | Reduced |
| STRS Ohio | 3,900 | $50.0K | 0.00% | +2,500+178.6% | Added |
| UBS Group AG | 3,776 | $48.7K | 0.00% | −203−5.1% | Reduced |
| American International Group, Inc. | 3,711 | $47.8K | 0.00% | +413+12.5% | Added |
| Morgan Stanley | 3,479 | $44.8K | 0.00% | −1,624−31.8% | Reduced |
| California State Teachers Retirement System | 1,641 | $21.2K | 0.00% | −638−28.0% | Reduced |
| Wells Fargo & Company | 1,465 | $18.9K | 0.00% | −1,380−48.5% | Reduced |
| Dorsey Wright & Associates | 1,396 | $18.0K | 0.01% | −48−3.3% | Reduced |
| Barclays PLC | 1,389 | $17.9K | 0.00% | +18+1.3% | Added |
| Royal Bank of Canada | 1,088 | $14.0K | 0.00% | −1,604−59.6% | Reduced |
| Amalgamated Bank | 1,039 | $13.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 841 | $10.8K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 566 | $7.30K | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 280 | $3.61K | 0.00% | −2,760−90.8% | Reduced |
| FMR LLC | 7 | $90 | 0.00% | −17−70.8% | Reduced |
| Citigroup Inc | 5 | $65 | 0.00% | −2,034−99.8% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,028−100.0% | Sold out |
| Edmond de Rothschild Holding S.A. | 0 | $0 | 0.00% | −22,820−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −11,012−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −3,970−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −411−100.0% | Sold out |